Acromegaly Completed Phase 2 Trials for Veldoreotide (DB12777)

Back to Acromegaly

Also known as: Acromegalic / Acromegaly (disorder)

IndicationStatusPhase
DBCOND0000951 (Acromegaly)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02235987
Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients.Treatment
NCT02217800
The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated AcromegalicsTreatment